Michael D. Loberg, Director at IGM Biosciences, Inc. (IGMS), bought 13,384 shares at $20.97 ($269K) on 2022-09-28, disclosed to the SEC on 2022-09-29.
Open-market purchase of $269k IGMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 533 | $0 | 0.0% |
| 2 | $19.99 | 507 | $10K | 3.8% |
| 3 | $20.97 | 6,172 | $129K | 48.1% |
| 4 | $20.97 | 6,172 | $129K | 48.1% |
| Total | $20.10 avg | 13,384 | $269K | 100% |
| Filing → |
| IGMS | BUY | 2019-09-20 | $93K | — | Filing → |
| ARQL | BUY | 2015-12-18 | $8K | — | Filing → |
| ARQL | BUY | 2015-12-17 | $3K | — | Filing → |